Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
Novo Nordisk A/S - share repurchase programme
March 27, 2023 10:07 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 27 March 2023 – On 1 February 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Oral semaglutide 25 mg and 50 mg demonstrate superior reductions in HbA1c and body weight versus 14 mg in people with type 2 diabetes in the PIONEER PLUS phase 3 trial
March 24, 2023 11:28 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 24 March 2023 – Novo Nordisk today announced headline results from the PIONEER PLUS trial, a phase 3b, 68-week, efficacy and safety trial with once-daily oral semaglutide 25 mg and...
Resolutions from the Annual General Meeting of Novo Nordisk A/S
March 23, 2023 11:16 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 23 March 2023 - Today, Novo Nordisk A/S held its Annual General Meeting. At the Annual General Meeting, Helge Lund, Chair of the Board of Directors communicated: “We are very...
Novo Nordisk A/S - share repurchase programme
March 20, 2023 07:50 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 20 March 2023 – On 1 February 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Novo Nordisk A/S - share repurchase programme
March 13, 2023 11:34 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 13 March 2023 – On 1 February 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Novo Nordisk announces changes in Executive Management
March 07, 2023 06:00 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 7 March 2023 – Novo Nordisk today announced the following changes in Executive Management. Monique Carter, executive vice president (EVP), Global People & Organisation, has...
Novo Nordisk A/S – Share repurchase programme
March 06, 2023 07:20 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 6 March 2023 – On 1 February 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Novo Nordisk to expand R&D presence in greater Boston area
March 02, 2023 02:10 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 2 March 2023 – Novo Nordisk just announced plans to expand its research and development (R&D) presence in the greater Boston metro area, creating one of its largest R&D hubs...
Novo Nordisk A/S – Share repurchase programme
February 27, 2023 09:10 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 27 February 2023 – On 1 February 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Notice for the Annual General Meeting of Novo Nordisk A/S
February 22, 2023 09:04 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 22 February 2023 – The Annual General Meeting of Novo Nordisk A/S will be held on: Thursday 23 March 2023 at 14.00 (CET) The Annual General Meeting is held as a partially...